December 2014, based on the results of this clinical trial, the FDA approved the 9-valent vaccine Gardasil 9, which protects against infection with HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58.
December 2014, based on the results of this clinical trial, the FDA approved the 9-valent vaccine Gardasil 9, which protects against infection with HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58.